Smith & Nephew PLC
DUS:NPW1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Smith & Nephew PLC
DUS:NPW1
|
UK |
|
Akari Therapeutics PLC
F:CLA
|
US |
|
M
|
MGM Resorts International
XBER:MGG
|
US |
|
PureTech Health PLC
F:0VQ0
|
US |
|
G
|
Gap Inc
BMV:GPS
|
US |
|
Y
|
Yext Inc
F:0YE
|
US |
|
S
|
STAG Industrial Inc
SWB:SW6
|
US |
|
W
|
Williams-Sonoma Inc
F:WM1
|
US |
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
|
F
|
First Majestic Silver Corp
NYSE:AG
|
CA |
|
Telefonica SA
MAD:TEF
|
ES |
|
A
|
Avenue Supermarts Ltd
BSE:540376
|
IN |
|
Shiseido Co Ltd
OTC:SSDOY
|
JP |
|
Z
|
Zijin Mining Group Co Ltd
F:FJZ
|
CN |
|
Isetan Mitsukoshi Holdings Ltd
OTC:IMHDF
|
JP |
|
M
|
Mobilezone Holding AG
SWB:TGE1
|
CH |
Wall St Price Targets
NPW1 Price Targets Summary
Smith & Nephew PLC
According to Wall Street analysts, the average 1-year price target for
NPW1 is 16.62 EUR with a low forecast of 14.54 EUR and a high forecast of 20.55 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NPW1's stock price target?
Price Target
16.62
EUR
According to Wall Street analysts, the average 1-year price target for
NPW1 is 16.62 EUR with a low forecast of 14.54 EUR and a high forecast of 20.55 EUR.
What is the Revenue forecast for Smith & Nephew PLC?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 5 years is 7%.
What is the Operating Income forecast for Smith & Nephew PLC?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 5 years is 12%.
What is the Net Income forecast for Smith & Nephew PLC?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 5 years is 2%.